Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
CEMEX SAB DE CV (CX)
NYSEMaterialsConstruction MaterialsSnapshot 2026-11-04
$10.71-2.01%
Close 2026-11-05 · 1-day change
NYSEMaterialsConstruction MaterialsSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.95 → 0.96 EPS · FY ending Dec 31, 2027 · 4 analysts
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 5, 2026 to Nov 4, 2026: (new ÷ prior − 1). Contributor count changed from 3 to 4; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for CX yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
dividend payments to shareholders | A supporting condition in CEMEX SAB DE CV's published investment case. The stated target is maintain or increase dividend payments. | Intact | dividends are cut or suspended | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
CX is a cyclical Materials business, meaning its results can be more sensitive to economic conditions than those of steadier businesses. The multi-year thesis is unclear because recent financial-performance history is too limited to establish its state.
The evidence does not provide a valuation level or specific market expectations, so whether CX looks cheap, fair, or expensive versus peers cannot be assessed. It reports low fragility, meaning no identified signal that current expectations are unusually vulnerable to a change in conditions.
Near term, earnings-surprise trends are weakening and industry peers have recently missed, though the estimated miss risk is described as low. The Materials sector backdrop weakened by 13.7 points, while the broader sector remains a stated tailwind; the evidence is not enough to establish CX's multi-year fundamental direction.
Near-term sector support depends in part on whether bellwethers CRH, VMC, and MLM continue to beat earnings and guide higher. Misses or lower guidance could weaken that support, while continued job-market weakness could raise recession concerns and pressure cyclical Materials businesses.
Over the next 1 to 3 years, the thesis remains uncertain: the sector backdrop offers support, but recent context weakened and the evidence on CX's own financial trend is limited. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in CEMEX SAB DE CV's published investment case. The stated target is >= $0.81 EPS in FY26 and >= $0.9 EPS in FY27. |
| Intact |
| EPS falls below $0.81 in FY26 or below $0.9 in FY27 |
Diluted EPS: $2.80 per share FY2026-Q3; GAAP. Published target: >= $0.81 EPS in FY26 and >= $0.9 EPS in FY27. Reported actuals cannot certify a consensus target without an explicit period and accounting-basis binding. Oct 26, 20262.8 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
operational regulatory environment | A primary condition in CEMEX SAB DE CV's published investment case. The stated target is no major adverse regulatory changes increasing costs materially. | Intact | significant regulatory rulings materially increasing operational costs | Qualitative condition This condition has no defined numerical measure. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.94 → $0.96 · observed estimates
$18.20B → $18.21B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.94 | $18,202,599,537 | 4 / 8 |
| 2026-07-25 | $0.90 | $18,007,616,350 | 5 / 15 |
| 2026-07-26 | $0.95 | $18,209,902,938 | 4 / 8 |
| 2026-07-27 | $0.92 | $18,014,919,760 | 5 / 15 |
| 2026-07-28 | $0.92 | $18,014,919,760 | 5 / 15 |
| 2026-07-29 | $0.92 | $18,014,907,880 | 5 / 15 |
| 2026-07-30 | $0.92 | $18,014,907,880 | 5 / 15 |
| 2026-07-31 | $0.95 | $18,232,198,921 | 4 / 8 |
| 2026-08-01 | $0.95 | $18,232,198,921 | 4 / 8 |
| 2026-08-02 | $0.92 | $18,045,021,540 | 5 / 15 |
| 2026-08-03 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-04 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-05 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-06 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-07 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-08 | $0.92 | $18,045,021,540 | 5 / 15 |
| 2026-08-09 | $0.92 | $18,045,021,540 | 5 / 15 |
| 2026-08-10 | $0.92 | $18,045,021,540 | 5 / 15 |
| 2026-08-11 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-12 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-13 | $0.92 | $18,045,021,540 | 5 / 15 |
| 2026-08-14 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-15 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-16 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-17 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-18 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-19 | $0.95 | $18,245,082,751 | 4 / 8 |
| 2026-08-20 | $0.95 | $18,332,032,469 | 4 / 8 |
| 2026-08-21 | $0.95 | $18,332,032,471 | 4 / 8 |
| 2026-08-22 | $0.95 | $18,332,032,471 | 4 / 8 |
| 2026-08-23 | $0.95 | $18,332,032,471 | 4 / 8 |
| 2026-08-24 | $0.95 | $18,332,032,471 | 4 / 8 |
| 2026-08-25 | $0.96 | $18,339,440,783 | 4 / 8 |
| 2026-08-26 | $0.96 | $18,339,440,783 | 4 / 8 |
| 2026-08-27 | $0.96 | $18,339,440,783 | 4 / 8 |
| 2026-08-28 | $0.96 | $18,339,440,783 | 4 / 8 |
| 2026-08-29 | $0.96 | $18,339,476,497 | 4 / 8 |
| 2026-08-30 | $0.96 | $18,339,476,497 | 4 / 8 |
| 2026-08-31 | $0.96 | $18,339,476,497 | 4 / 8 |
| 2026-09-01 | $0.96 | $18,339,476,497 | 4 / 8 |
| 2026-09-02 | $0.96 | $18,339,476,497 | 4 / 8 |
| 2026-09-03 | $0.96 | $18,339,463,770 | 4 / 8 |
| 2026-09-04 | $0.96 | $18,339,463,770 | 4 / 8 |
| 2026-09-05 | $0.96 | $18,339,463,770 | 4 / 8 |
| 2026-09-06 | $0.96 | $18,339,463,770 | 4 / 8 |
| 2026-09-07 | $0.96 | $18,339,463,770 | 4 / 8 |
| 2026-09-08 | $0.96 | $18,339,463,770 | 4 / 8 |
| 2026-09-09 | $0.96 | $18,339,463,768 | 4 / 8 |
| 2026-09-10 | $0.96 | $18,339,463,768 | 4 / 8 |
| 2026-09-11 | $0.96 | $18,339,463,768 | 4 / 8 |
| 2026-09-12 | $0.96 | $18,339,463,768 | 4 / 8 |
| 2026-09-13 | $0.96 | $18,339,463,768 | 4 / 8 |
| 2026-09-14 | $0.96 | $18,339,463,768 | 3 / 8 |
| 2026-09-15 | $0.96 | $18,339,463,768 | 3 / 8 |
| 2026-09-16 | $0.96 | $18,379,606,625 | 3 / 8 |
| 2026-09-17 | $0.96 | $18,379,606,625 | 3 / 8 |
| 2026-09-18 | $0.96 | $18,379,606,625 | 3 / 8 |
| 2026-09-19 | $0.96 | $18,379,606,625 | 3 / 8 |
| 2026-09-20 | $0.95 | $18,385,606,625 | 3 / 8 |
| 2026-09-21 | $0.95 | $18,385,606,625 | 3 / 8 |
| 2026-09-22 | $0.95 | $18,385,606,625 | 3 / 8 |
| 2026-09-23 | $0.95 | $18,385,606,625 | 3 / 8 |
| 2026-09-24 | $0.95 | $18,385,606,625 | 3 / 8 |
| 2026-09-25 | $0.95 | $18,385,606,625 | 3 / 8 |
| 2026-09-26 | $0.95 | $18,385,606,625 | 3 / 8 |
| 2026-09-27 | $0.95 | $18,385,606,625 | 3 / 8 |
| 2026-09-28 | $0.95 | $18,385,606,625 | 3 / 8 |
| 2026-09-29 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-09-30 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-01 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-02 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-03 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-04 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-05 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-06 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-07 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-08 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-09 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-10 | $0.95 | $18,377,294,482 | 3 / 8 |
| 2026-10-11 | $0.95 | $18,345,086,768 | 3 / 8 |
| 2026-10-12 | $0.95 | $18,345,086,768 | 3 / 8 |
| 2026-10-13 | $0.95 | $18,345,086,768 | 3 / 8 |
| 2026-10-14 | $0.95 | $18,345,086,768 | 3 / 8 |
| 2026-10-15 | $0.95 | $18,345,086,768 | 3 / 7 |
| 2026-10-16 | $0.96 | $18,344,760,525 | 3 / 7 |
| 2026-10-17 | $0.96 | $18,344,760,525 | 3 / 7 |
| 2026-10-18 | $0.96 | $18,344,760,525 | 3 / 7 |
| 2026-10-19 | $0.96 | $18,344,760,525 | 3 / 7 |
| 2026-10-20 | $0.96 | $18,344,760,525 | 3 / 7 |
| 2026-10-21 | $0.96 | $18,344,760,525 | 3 / 7 |
| 2026-10-22 | $0.95 | $18,294,243,157 | 3 / 7 |
| 2026-10-23 | $0.95 | $18,294,243,157 | 3 / 7 |
| 2026-10-24 | $0.95 | $18,294,243,157 | 3 / 7 |
| 2026-10-25 | $0.95 | $18,294,243,157 | 3 / 7 |
| 2026-10-26 | $0.95 | $18,294,243,157 | 3 / 7 |
| 2026-10-27 | $0.95 | $18,294,243,157 | 3 / 7 |
| 2026-10-28 | $0.95 | $18,225,514,411 | 3 / 8 |
| 2026-10-29 | $0.94 | $18,221,347,744 | 4 / 8 |
| 2026-10-30 | $0.94 | $18,197,783,774 | 4 / 8 |
| 2026-10-31 | $0.94 | $18,197,783,774 | 4 / 8 |
| 2026-11-01 | $0.96 | $18,197,783,774 | 4 / 8 |
| 2026-11-02 | $0.96 | $18,197,783,774 | 4 / 8 |
| 2026-11-03 | $0.96 | $18,210,160,335 | 4 / 8 |
| 2026-11-04 | $0.96 | $18,210,160,335 | 4 / 8 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 12 Buy / Strong Buy · 3 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 4 recorded
1 raises · 1 cuts · 0 unchanged · 1 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.